Llwytho...
BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly
Despite the great success of small molecule inhibitors in the treatment of patients with BRAF(V600E) mutated melanoma, the response to these drugs remains transient and patients eventually relapse within a few months, highlighting the need to develop novel combination therapies based on the understa...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Sci Rep |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Publishing Group UK
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533289/ https://ncbi.nlm.nih.gov/pubmed/31123282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-44112-7 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|